5 Star Review

"Most helpful, steered us in the right direction for treatmen...." see more

Elaine C. - Mesothelioma Patient

5 Star Review

"Because of their guidance, I was able to navigate getting my...." see more

Deanna B. - Daughter of a Mesothelioma Patient

5 Star Review

"Hearing the news about my mother's diagnosis was heartbreaki...." see more

Danielle W. - Daughter of a Mesothelioma Patient

5 Star Review

"My son Carlos was diagnosed with this terrible and unknown d...." see more

Martha M. - Mother of a Mesothelioma Patient

5 Star Review

"Extremely communicative and helped my dad get an appointment...." see more

Sunni H. - Loved One of a Mesothelioma Patient

5 Star Review

"Danielle DiPietro was an invaluable resource for me. Her sug...." see more

Deborah C. - Spouse of a Mesothelioma Patient

5 Star Review

"I was very grateful and appreciative of Dr. Smart from The M...." see more

Kimberlin C. - Spouse of a Mesothelioma Patient

5 Star Review

"In January of 2016, my husband was diagnosed with peritoneal...." see more

Gloria R. - Spouse of a Mesothelioma Patient

Expertise:
Cytoreductive Surgery
HIPEC
Speciality:
Surgical Oncology
Gender:
Male
Language:
English
Primary Location
Lung Institute at Baylor College of Medicine 6620 Main St Suite 1325 Houston, TX 77030 Directions

Get to Know Dr. Eugene Choi

Surgical oncologist Dr. Eugene Choi strongly believes in a personalized approach to treating his patients with peritoneal mesothelioma. Choi is part of the specialized, multidisciplinary approach that has made Baylor College of Medicine one of the top treatment facilities in the country for pleural and peritoneal mesothelioma.

“There is generally a lack of understanding of this disease and its treatment,” Choi said. “It’s so rare. That’s why you need to find a center that treats a high volume and knows how to handle it.”

Choi has experience in both cytoreductive surgery and accompanying hyperthermic intraperitoneal chemotherapy, known as HIPEC. Less than a third of mesothelioma patients, though, embark on those aggressive treatment options.

Choi estimates that he sees 20 to 25 peritoneal mesothelioma patients annually. There are only an estimated 300 to 400 patients in the country diagnosed each year with peritoneal mesothelioma. He believes each one should receive a personalized approach to mesothelioma treatment.

Before joining Baylor College of Medicine, Choi completed a clinical fellowship at nearby University of Texas MD Anderson Cancer Center, where he received a Clinical Excellence Award. He completed a general surgical residency at the University of Chicago, where he also received his medical degree. He completed another fellowship at the University of Pennsylvania School of Medicine.

Specialties of Dr. Eugene Choi

  • Peritoneal mesothelioma
  • HIPEC
  • Research

Dr. Eugene Choi’s Experience and Medical Education

  • University of Chicago Pritzker School of Medicine (M.D.)
  • University of Chicago (Residency)
  • University of Pennsylvania and MD Anderson Cancer Center (Fellowships)

Awards and Certifications

  • Board certified in general surgery and surgical oncology
  • American Cancer Society Institutional Research Grant Recipient, University of Chicago Pritzker School of Medicine
  • Clinical Excellence Award, University of Texas MD Anderson Cancer Center
  • American Society of Clinical Oncology Foundation Merit Award
  • Cancer Research Foundation Young Investigator Award
  • Excellence in Clinical Teaching, University of Chicago, Department of Surgery

Publications of Dr. Eugene Choi

  • Gilliland, T.M. et al. (2017, March 7). Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients.
  • Thomas, R.M. et al. (2014, July). Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford).
  • Cohen, E.E. et al. (2009, January 1). A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Research.